Analysis by our Investment Advisor on Weight-Loss Drugs, Published in AGEFI Finance
January 13, 2025
Paul de la Baume, Investment Advisor at BNP Paribas Wealth Management Switzerland, explores in an article published in AGEFI Finance the emergence of weight-loss drugs as a promising investment theme. These treatments could revolutionize the healthcare sector and offer new opportunities for investors.
